- Nachrichtendetail
-
13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Frankfurt | 87,480 | 30.05.24 08:20:01 | -0,610 | -0,69% | 88,280 | 88,350 | 87,480 | 88,090 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 882,200 | 30.05.24 08:12:02 | -12,800 | -1,43% | 881,200 | 892,000 | 882,200 | 895,000 |
